Icon plc (ICLR) | Financial Analysis & Statements
Icon plc Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Sep 2025Income Metrics
Revenue
2.0B
Gross Profit
554.4M
27.14%
Operating Income
258.9M
12.67%
Net Income
2.4M
0.12%
EPS (Diluted)
$0.03
Balance Sheet Metrics
Total Assets
16.5B
Total Liabilities
7.2B
Shareholders Equity
9.3B
Debt to Equity
0.77
Cash Flow Metrics
Operating Cash Flow
232.4M
Free Cash Flow
333.9M
Revenue & Profitability Trend
Quarter Income Flow
Sep 30, 2025
Annual Income Flow
2024
Icon plc Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 8.3B | 8.1B | 7.7B | 5.5B | 2.8B |
| Cost of Goods Sold | 5.8B | 5.7B | 5.5B | 4.0B | 2.0B |
| Gross Profit | 2.4B | 2.4B | 2.2B | 1.5B | 817.4M |
| Gross Margin % | 29.4% | 29.6% | 28.6% | 27.5% | 29.2% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 728.3M | 768.6M | 778.8M | 585.3M | 342.4M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 728.3M | 768.6M | 778.8M | 585.3M | 342.4M |
| Operating Income | 1.2B | 1.0B | 866.1M | 607.9M | 408.8M |
| Operating Margin % | 14.7% | 12.9% | 11.2% | 11.1% | 14.6% |
| Non-Operating Items | |||||
| Interest Income | 8.6M | 5.0M | 2.3M | 574.0K | 2.7M |
| Interest Expense | 206.2M | 311.0M | 209.2M | 93.8M | 13.4M |
| Other Non-Operating Income | -121.7M | -89.6M | -70.8M | -304.8M | -17.3M |
| Pre-tax Income | 869.2M | 624.5M | 567.9M | 196.7M | 381.2M |
| Income Tax | 77.7M | 11.7M | 59.4M | 41.3M | 47.9M |
| Effective Tax Rate % | 8.9% | 1.9% | 10.5% | 21.0% | 12.6% |
| Net Income | 791.5M | 612.3M | 505.3M | 153.2M | 333.0M |
| Net Margin % | 9.6% | 7.5% | 6.5% | 2.8% | 11.9% |
| Key Metrics | |||||
| EBITDA | 1.7B | 1.6B | 1.4B | 910.2M | 478.1M |
| EPS (Basic) | $9.60 | $7.46 | $6.21 | $2.28 | $6.27 |
| EPS (Diluted) | $9.53 | $7.40 | $6.13 | $2.25 | $6.22 |
| Basic Shares Outstanding | 82482764 | 82101813 | 81532320 | 67110186 | 52859911 |
| Diluted Shares Outstanding | 82482764 | 82101813 | 81532320 | 67110186 | 52859911 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Icon plc Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 538.8M | 378.1M | 288.8M | 752.2M | 840.3M |
| Short-term Investments | 0 | 2.0M | 1.7M | 1.7M | 1.7M |
| Accounts Receivable | 1.4B | 1.8B | 1.7B | 1.3B | 715.3M |
| Inventory | - | - | - | - | - |
| Other Current Assets | 140.4M | 132.1M | 137.1M | 114.3M | 53.5M |
| Total Current Assets | 3.5B | 3.4B | 3.2B | 2.9B | 2.1B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 202.7M | 196.6M | 213.8M | 227.3M | 129.1M |
| Goodwill | 21.7B | 21.9B | 22.2B | 22.8B | 1.9B |
| Intangible Assets | 3.6B | 3.9B | 4.3B | 4.7B | 66.5M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 147.6M | 152.1M | 169.1M | 208.1M | 50.7M |
| Total Non-Current Assets | 13.3B | 13.6B | 14.0B | 14.4B | 1.3B |
| Total Assets | 16.9B | 17.0B | 17.2B | 17.4B | 3.4B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 704.6M | 131.6M | 81.2M | 90.8M | 51.1M |
| Short-term Debt | 66.5M | 146.6M | 98.8M | 105.1M | 24.3M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 129.4M | 878.9M | 961.3M | 899.6M | 375.4M |
| Total Current Liabilities | 2.8B | 2.8B | 2.7B | 2.5B | 1.1B |
| Non-Current Liabilities | |||||
| Long-term Debt | 3.5B | 3.8B | 4.7B | 5.5B | 409.3M |
| Deferred Tax Liabilities | 812.5M | 899.1M | 988.6M | 1.1B | 10.4M |
| Other Non-Current Liabilities | 83.5M | 31.3M | 25.2M | 26.3M | 16.0M |
| Total Non-Current Liabilities | 4.6B | 4.9B | 6.0B | 6.8B | 461.4M |
| Total Liabilities | 7.4B | 7.7B | 8.7B | 9.3B | 1.6B |
| Equity | |||||
| Common Stock | 6.6M | 6.7M | 6.6M | 6.6M | 4.6M |
| Retained Earnings | 2.7B | 2.4B | 1.8B | 1.4B | 1.3B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 9.5B | 9.2B | 8.5B | 8.1B | 1.9B |
| Key Metrics | |||||
| Total Debt | 3.6B | 3.9B | 4.8B | 5.6B | 433.6M |
| Working Capital | 734.1M | 585.9M | 538.5M | 462.3M | 979.0M |
Balance Sheet Composition
Icon plc Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 791.5M | 612.3M | 505.3M | 153.2M | 333.0M |
| Depreciation & Amortization | 488.5M | 586.0M | 569.5M | 315.0M | 66.1M |
| Stock-Based Compensation | 45.9M | 55.7M | 70.5M | 133.8M | 26.3M |
| Working Capital Changes | -56.5M | -114.8M | -550.2M | 135.0M | 119.8M |
| Operating Cash Flow | 1.3B | 1.1B | 544.4M | 798.6M | 567.2M |
| Investing Activities | |||||
| Capital Expenditures | -168.1M | -140.7M | -142.2M | -93.8M | -40.9M |
| Acquisitions | -84.2M | -71.8M | 0 | -5.9B | -50.4M |
| Investment Purchases | -17.3M | -16.8M | -6.1M | -4.6M | -3.3M |
| Investment Sales | 2.7M | 2.6M | 2.4M | 997.0K | 48.0M |
| Investing Cash Flow | -266.8M | -226.7M | -145.9M | -6.0B | -46.6M |
| Financing Activities | |||||
| Share Repurchases | -500.0M | 0 | -100.0M | 0 | -175.0M |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 2.3B | 370.0M | 75.0M | 5.9B | 350.0M |
| Debt Repayment | -2.7B | -1.3B | -875.0M | -877.8M | -350.0M |
| Financing Cash Flow | -873.4M | -895.0M | -900.0M | 10.0B | -221.5M |
| Free Cash Flow | 1.1B | 1.0B | 421.2M | 735.4M | 527.2M |
| Net Change in Cash | 123.8M | 8.2M | -501.5M | 4.8B | 299.1M |
Cash Flow Trend
Icon plc Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
15.52
Forward P/E
9.42
Price to Book
0.94
Price to Sales
1.11
PEG Ratio
-0.16
Profitability Ratios
Profit Margin
7.40%
Operating Margin
12.67%
Return on Equity
6.27%
Return on Assets
4.20%
Financial Health
Current Ratio
1.06
Debt to Equity
38.26
Beta
1.28
Per Share Data
EPS (TTM)
$7.42
Book Value per Share
$122.25
Revenue per Share
$101.62
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ICLR | 9.0B | 15.52 | 0.94 | 6.27% | 7.40% | 38.26 |
| Thermo Fisher | 174.6B | 25.84 | 3.31 | 13.52% | 15.15% | 82.91 |
| Danaher | 126.4B | 34.61 | 2.40 | 7.08% | 14.89% | 37.17 |
| Revvity | 9.7B | 45.77 | 1.46 | 3.22% | 8.45% | 46.87 |
| Charles River | 8.3B | 681.33 | 2.61 | -4.23% | -3.60% | 81.95 |
| Qiagen N.V | 7.9B | 18.76 | 2.09 | 11.57% | 20.33% | 48.56 |
Financial data is updated regularly. All figures are in the company's reporting currency.





